Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report

Abdurahman Alloghbi; James Ninia; Bayan Alshare; Jeffrey Hotaling; Syed Raza; Ammar Sukari

doi:10.1002/ccr3.5228

Clinical Case Reports (Dec 2021)

Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report

Abdurahman Alloghbi,
James Ninia,
Bayan Alshare,
Jeffrey Hotaling,
Syed Raza,
Ammar Sukari

Affiliations

Abdurahman Alloghbi: Department of Oncology Karmanos Cancer InstituteWayne State University Detroit Michigan USA
James Ninia: School of Medicine Wayne State University Detroit Michigan USA
Bayan Alshare: Department of Oncology Karmanos Cancer InstituteWayne State University Detroit Michigan USA
Jeffrey Hotaling: Department of Surgical Oncology Karmanos Cancer Institute Detroit Michigan USA
Syed Raza: Department of Surgical Oncology Karmanos Cancer Institute Detroit Michigan USA
Ammar Sukari: Department of Oncology Karmanos Cancer InstituteWayne State University Detroit Michigan USA

DOI: https://doi.org/10.1002/ccr3.5228
Journal volume & issue: Vol. 9, no. 12
pp. n/a – n/a

Abstract

Read online

Abstract This is a case of a 60‐year‐old man living with HIV who presented with advanced cutaneous squamous cell carcinoma. After workup, medical and surgical treatment, and disease recurrence, he achieved a complete response with no unexpected toxicities after immunotherapy with cemiplimab.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords